Bharat Dixit
Chief Technology Officer Adiso Therapeutics
Bharat Dixit is the Chief Technology Officer at Adiso Therapeutics, bringing a wealth of experience in the microbiome industry. For over 15 years, he has been at the forefront of process development and manufacturing, working with nearly every CDMO across the globe.
This has given him an intimate understanding of the complexities of outsourcing and manufacturing in the life sciences. Bharat is also involved in setting up a new microbiome-focused company.
A previous speaker at Hanson Wade’s microbiome meetings, he offers deep insights into the past, present, and future of the field.
Seminars
Wednesday 11th November 2026
Chair’s Opening Remarks
8:55 am
Wednesday 11th November 2026
Optimizing LBP & FMT Commercialization Models to Identifying Sustainable Microbiome Growth Strategies
9:00 am
- Evaluating consumer commercialization approaches to identifying scalable market adoption strategies for LBP & FMT developers
- Assessing reimbursement-driven therapeutic models to determining long-term revenue generation opportunities across microbiome markets
- Identifying customer engagement techniques to strengthening awareness, retention & downstream therapeutic demand
Wednesday 11th November 2026
Panel Discussion: Sharing Regulatory Navigation Strategies Across Global Agencies to Reduce Uncertainty & Accelerate Clinical Progression
1:45 pm
- Benchmarking regulatory pathways used across FDA, EMA & national authorities to clarify expectations and reduce trial approval uncertainty
- Comparing real-world regulatory interactions including key questions, feedback loops & submission strategies to strengthen future applications
- Identifying common pitfalls in CMC, trial design & product characterisation to proactively mitigate delays in regulatory approval processes
Wednesday 11th November 2026
Chair’s Closing Remarks
4:15 pm
